- Filed
- Apr 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Apr 15, 2025 | 5.09M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 4.35M sh |
| Capex | FY 2024 · Dec 31, 2023 | $218K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$15.28M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $2.62M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $5.86M |
| Current Assets | FY 2024 · Dec 31, 2023 | $15.54M |
| Total Assets | FY 2024 · Dec 31, 2023 | $25.1M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$5.28 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$5.28 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $10.37M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $14.49M |
| Net Income | FY 2024 · Dec 31, 2023 | −$22.94M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$23.77M |
| Revenue | FY 2024 · Dec 31, 2023 | $1.1M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $6.83M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $36.64M |